Protective efficacy of killed Mycoplasma pneumoniae vaccine measured in large-scale studies in a military population.
D000293:Adolescent; D000328:Adult; D000917:Antibody Formation; D000942:Antigens, Bacterial; D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000009:adverse effects; D001431:Bacteriological Techniques; D001991:Bronchitis / Q000517:prevention & control; D002986:Clinical Trials as Topic; D003168:Complement Fixation Tests; D006801:Humans; D008297:Male; D008887:Military Medicine; D009174:Mycoplasma / Q000302:isolation & purification; D009175:Mycoplasma Infections / Q000175:diagnosis / Q000517:prevention & control*; D009500:Neutralization Tests; D010919:Placebos; D011014:Pneumonia / Q000517:prevention & control; D012141:Respiratory Tract Infections / Q000517:prevention & control*; D012698:Serologic Tests; D013997:Time Factors; D014611:Vaccination / Q000009:adverse effects
D000942:Antigens, Bacterial; D001428:Bacterial Vaccines; D010919:Placebos